149 related articles for article (PubMed ID: 1192430)
1. Variables and specificity of in vitro lymphocyte-mediated cytotoxicity in human melanoma.
Mukherji B; Vassos D; Flowers A; Binder SC; Nathanson L
Cancer Res; 1975 Dec; 35(12):3721-30. PubMed ID: 1192430
[TBL] [Abstract][Full Text] [Related]
2. Cell-mediate cytotoxicity in vitro of human lymphocytes against a tissue culture melanoma cell line (igr3).
Peter HH; Pavie-Fischer J; Fridman WH; Aubert C; Cesarini JP; Roubin R; Kourilsky FM
J Immunol; 1975 Aug; 115(2):539-48. PubMed ID: 1171141
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous and antibody-dependent cellular cytotoxicity in melanoma patients and healthy control presons.
Peter HH; Knoop F; Kalden JR
Z Immunitatsforsch Exp Klin Immunol; 1976 Apr; 151(3):263-81. PubMed ID: 134545
[TBL] [Abstract][Full Text] [Related]
4. Problems in the clinical use of the microcytotoxicity assay for measuring cell-mediated immunity to tumor cells.
Heppner G; Henry E; Stolbach L; Cummings F; McDonough E; Calabresi P
Cancer Res; 1975 Aug; 35(8):1931-7. PubMed ID: 1149017
[TBL] [Abstract][Full Text] [Related]
5. Humoral and cellular immune reactions 'in vitro' against allogeneic and autologous human melanoma cells.
Peter HH; Kalden JR; Seeland P; Diehl V; Eckert G
Clin Exp Immunol; 1975 May; 20(2):193-207. PubMed ID: 765012
[TBL] [Abstract][Full Text] [Related]
6. Effects of human lymphocytes on cultured normal and malignant cells.
Pierce GE; DeVald BL
Cancer Res; 1975 Jul; 35(7):1830-9. PubMed ID: 805664
[TBL] [Abstract][Full Text] [Related]
7. Antibody-dependent cell-mediated cytotoxicity (ADCC) and cell-mediated cytotoxicity (CMC) to HBsAg-coated target cells in patients with hepatitis B and chronic hepatitis (CAH).
Warnatz H; Rösch W; Gerlich W; Gutmann W
Clin Exp Immunol; 1979 Jan; 35(1):133-40. PubMed ID: 371882
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
Bonavida B; Lebow LT; Bradley TP
J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
[TBL] [Abstract][Full Text] [Related]
9. Differential cytotoxicity of activated lymphocytes on allogeneic and xenogeneic target cells. III. Species specificity of lymphocyte target cell recognition in vitro.
Stejskal V; Perlmann P
Eur J Immunol; 1976 May; 6(5):347-52. PubMed ID: 991906
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous cytotoxicity (SCMC) of normal human lymphocytes against a human melanoma cell line: a phenomenon due to a lymphotoxin-like mediator.
Peter HH; Eife RF; Kalden JR
J Immunol; 1976 Feb; 116(2):342-8. PubMed ID: 1082453
[TBL] [Abstract][Full Text] [Related]
11. Disease and non-disease-related cell-mediated cytotoxicity in humans.
Bloom ET; Seeger RC
Cancer Res; 1976 Apr; 36(4):1361-6. PubMed ID: 1260761
[TBL] [Abstract][Full Text] [Related]
12. Application of a flow cytometric cytotoxicity assay for monitoring cancer vaccine trials.
Zaritskaya L; Shafer-Weaver KA; Gregory MK; Strobl SL; Baseler M; Malyguine A
J Immunother; 2009; 32(2):186-94. PubMed ID: 19238018
[TBL] [Abstract][Full Text] [Related]
13. Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells.
Allavena P; Introna M; Sessa C; Mangioni C; Mantovani A
J Natl Cancer Inst; 1982 Apr; 68(4):555-62. PubMed ID: 6175786
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanomas.
Itoh K; Tilden AB; Balch CM
Cancer Res; 1986 Jun; 46(6):3011-7. PubMed ID: 3486040
[TBL] [Abstract][Full Text] [Related]
15. An in vitro method for study of human lymphocyte cytotoxicity against mumps-virus-infected target cells.
Andersson T; Stejskal V; Harfast B
J Immunol; 1975 Jan; 114(1 Pt 1):237-43. PubMed ID: 803527
[TBL] [Abstract][Full Text] [Related]
16. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic lymphocyte cytotoxicity (ALC) in rats: establishment of an in vitro assay, and direct evidence that cells with natural killer (NK) activity are involved in ALC.
Rolstad B; Fossum S
Immunology; 1987 Feb; 60(2):151-7. PubMed ID: 2434415
[TBL] [Abstract][Full Text] [Related]
18. Induction of cytotoxic T lymphocytes from the peripheral blood of a hepatocellular carcinoma patient using melanoma antigen-1 (MAGE-1) peptide.
Lu J; Leng X; Peng J; Mou D; Pang X; Shang X; Chen W
Chin Med J (Engl); 2002 Jul; 115(7):1002-5. PubMed ID: 12150730
[TBL] [Abstract][Full Text] [Related]
19. T lymphocyte induction of non-T cell-mediated nonspecific cytotoxicity. I. Introduction mechanisms.
Mackler BF; O'Neill PA; Meistrich M
Eur J Immunol; 1977 Feb; 7(2):55-61. PubMed ID: 326561
[TBL] [Abstract][Full Text] [Related]
20. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
de Vries JE; Spits H
J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
